dMY Technology Group II – Transaction Call, October 27, 2020
We have a unique rights strategy, whereby, as I mentioned before, we work with a vast number of sports to collect the underlying data that’s required for sportsbooks through contra-relationships or swapping our software with those sportsbooks. It means that we’re very cost effective in the way that we collect our data, it means it’s very scalable, and it gives us a very strong position in the market, where we’re giving a fair deal back to sports, and that they’re benefiting from the sportsbook betting revenues that are generating, and the sportsbooks are benefiting from the value that’s being offered to them by the sports leagues. On that basis, we will end up in a very competitive market with other players who are looking to acquire rights, but the benefits of our lower tier model, where we’re contra-ing our software in exchange for rights, give us the ability to be very insulated from any one particular win or loss of any Tier 1 event. You can see the results of this strategy and official data on this slide. Over the last six or seven years, we have grown the number of official data rights that we have, from 2014, where we had very few, to over 170,000 now, which is the vast proportion of a sportsbooks’ official data requirements.
This slide really brings our business together. On the left-hand side, you have the sports leagues, where they are granting official rights to their data in exchange for our technology. Taking that data, wrapping it in our software, providing it to sportsbooks creates an increased demand on that data, but also an increased demand for new data. That allows us to go back to the sports leagues, offer further technology in exchange for official rights. This virtuous circle is something that we’ve been very successful in pioneering and, as Nick will speak to you about in the next few slides, we are only at the beginning of that journey.
Nick Taylor
Yes, hi. Thanks, Mark. I’m Nick Taylor, I’m the CFO. I’ve been with Genius a year now, and I just want to talk you through the next few slides.
As you’ve heard, we’re uniquely placed to take advantage of the fast-growing sports betting market, and there are plenty of estimates out there about the size of the market, one of which is set out in Slide 15, going out to 2025, and you can just see that the TAM doubles in those five years, but there are two important points to draw out of this.
Firstly, the U.S. market, although very nascent, will be the largest growing market in the next five years, and I’ll touch on our U.S. positioning in a second.
And secondly, and equally as important, and it’s sometimes overlooked, given the excitement of the liberalization of the U.S. market, is that there’s still significant growth in other markets, as you can see on the slide, including Europe, which you can see has still a very healthy double-digit CAGR growth, and, as Mark explained, has been our core market to date and one of which we have been very successful in.
Looking at this through a U.S. lens, this is about all the pieces of the jigsaw in place to replicate our success in Europe across the United States. I just want to spend a minute or two drawing out a couple of key points.
Firstly, we are in a strong position with high-profile rights.
Secondly, we have market-leading ad tech solutions in the U.S. market, which is set to explode as sportsbooks compete for customer acquisition with increased marketing dollar spend and we are perfectly positioned to capture our share of this.
Thirdly, we have the right business model, which, through our relationships with all key sportsbooks, means we share in the upside as our partners grow over time. In addition to this, we also have key relationships with other B2B technology suppliers. To Mark’s point earlier, these companies are competing with each other and, to some extent, we’re agnostic to who wins, as we have relationships across the industry.
5
ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only. 1-888-562-0262 1-604-929-1352 www.viavid.com